Fact CheckerSign in

NCT04328207Completed

Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

Using Telemedicine to Prevent Blindness in an At-risk Rural Alabama Population

Source: ClinicalTrials.gov · Last updated 7 Aug 2025

Brief summary (registry, in English)

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform to manage this disease in community-based clinics so that further vision loss is prevented. Our goal is to improve the quality and accessibility of glaucoma detection and management among a vulnerable and at-risk segment of our population.

Status (registry)
Completed
Study type
Interventional
Enrollment
900 (actual)
First submitted
27 Mar 2020
Start date
Nov 2020
Primary completion date
Jul 2024
Lead sponsor
University of Alabama at Birmingham
NCT number
NCT04328207

What you commit to

  • Study type: Interventional
  • Participants enrolled: 900
  • From Nov 2020 to the primary completion date, Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • African American or Hispanic ≥40 years
  • Non-Hispanic white ≥50 years
  • Anyone ≥ 18 years with diabetes
  • Anyone ≥ 18 years with a glaucoma associated diagnosis
  • Anyone ≥ 18 years with a family history of glaucoma
  • All enrollees must be able to speak and understand English

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alabama at Birmingham
Coordinator of this site? Confirm its status
BirminghamUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.